Mottiwala Aziz

Related Filers (2)

Other (1)

144
Thursday, 3/16/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (14)

4
Thursday, 3/23/2023
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/21/2023
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/17/2023
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/10/2023
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/26/2022
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/11/2022
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/10/2021
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/4/2021
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/14/2021
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/8/2021
Tarsus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/15/2020
Tarsus Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Friday, 9/20/2019
OPIANT PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
Show More